Skip to content

Er:YAG Laser for Treatment of Enlarged Pores

The Efficacy and Safety of Erbium:Yttrium Aluminum Garnet Laser for Treatment of Enlarged Pores: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02544958
Enrollment
24
Registered
2015-09-09
Start date
2015-05-31
Completion date
2016-08-31
Last updated
2016-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enlarged Pores

Keywords

Enlarged pores, Er:YAG laser

Brief summary

To investigate the efficacy of Erbium:Yttrium aluminum garnet laser (Er:YAG) in the treatment of enlarged pores.

Detailed description

* Enlarged pores are caused by multifactorial factors such as sex, genetics, aging, etc. * The gold of the treatment is to recollagenesis of the dermis and resurfacing of the epidermis. * Modalities that have been proved on their efficacy for enlarged pores treatment included topical retinoic acid, chemical peeling, intense pulsed light, radiofrequency device, laser such as Q-switched and Long Pulsed Neodymium-Doped Yttrium-Aluminum-Garnet (Nd:YAG) 1,064nm, Long pulse duration pulsed dye laser 595nm, etc. * Er:YAG laser is an ablative laser which creates both recollagenesis and resurfacing. It ha been proved to be safe and effective in the treatment of atrophic acne scar. * However, the efficacy of this laser for enlarged treatment has not yet been established.

Interventions

DEVICEEr:YAG laser

Er:YAG laser treats enlarged pores on both sides of the face for 4 treatments of 1 month interval.

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Visible enlarged pores on both sides of the face * Fitzpatrick skin type 3-5

Exclusion criteria

* Patients with lesions with any clinical suspicion of being pre-cancerous or skin malignancies of any kind * Patients who have photosensitive dermatoses * Pregnancy and lactation woman * Patients with wound infections (herpes, other) on the day of treatment * Patients with moderate and severe inflammatory acne, Immunosuppressed patients, history of vitiligo * Patients with unrealistic concerns/expectations and inability to do the appropriate post-operative care

Design outcomes

Primary

MeasureTime frameDescription
The efficacy of Er:YAG laser in the treatment of enlarged pores (measurement of skin texture using UVA-light video camera)1 month after 4 treatmentsmeasurement of skin texture using UVA-light video camera

Secondary

MeasureTime frameDescription
Hyperpigmentation side effect of Er:YAG laser in the treatment of enlarged poresFollow-up period:1 month after 1st treatment, 1 month after 2nd treatment, 1 month after 3rd treatment and 1-,3-,and 6-month after 4th treatmentBy investigators' observation of hyperpigmentation
Hypopigmentation side effect of Er:YAG laser in the treatment of enlarged poresFollow-up period:1 month after 1st treatment, 1 month after 2nd treatment, 1 month after 3rd treatment and 1-,3-,and 6-month after 4th treatmentBy investigators' observation of hypopigmentation
Erythema side effect of Er:YAG laser in the treatment of enlarged poresFollow-up period:1 month after 1st treatment, 1 month after 2nd treatment, 1 month after 3rd treatment and 1-,3-,and 6-month after 4th treatmentBy investigators' observation of erythema
The patients satisfaction using Quartile grading scale of improvementFollow-up period:1 month after 1st treatment, 1 month after 2nd treatment, 1 month after 3rd treatment and 1-,3-,and 6-month after 4th treatmentBy using Quartile grading scale of improvement; 0 = not improve, 1= 1-25% improvement, 2 = 26-50% improvement, 3 = 51-75% improvement and 4 = 76-100% improvement

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026